Health Condition 1: H259- Unspecified age-related cataract Health Condition 2: H409- Unspecified glaucoma
Conditions
Interventions
Intervention1: Elisar-Novel Ophthalmic Analyzer: Prospective observational study to observe the repeatability and reproducibility of device parameters.
Control Intervention1: NIL: NIL
Sponsors
Elisar Vision Technology
Eligibility
Inclusion criteria
Inclusion criteria: For Stage 1 Study Controls 1. Patients said to be clinically normal by an ophthalmologist. Cataract 1. Patients diagnosed with cataracts that are graded using the LOCS grading method by an ophthalmologist. 2. Eyes that are undergoing cataract surgery candidates in the clinic. For Stage 2 Study Controls 1. All subjects had no history of any ocular diseases, a fundus appearance should be normal. Glaucoma 1. A definitive diagnosis of glaucoma, defined as glaucomatous visual field loss with an accompanying optic nerve abnormality typical of glaucoma. 2. The glaucoma needed to be stable, and the patient required at least two reliable SITA Standard 24-2 HVF examinations.
Exclusion criteria
Exclusion criteria: For Stage 1 Study 1. Presence of keratoconus or suspect keratoconus, a previous diagnosis of dry eye, history of any corneal disease or trauma, any kind of ocular surgery, and use of contact lens past month. 2. Eyes with retinopathy or maculopathy, eyes with a history of corneal disease, pseudophakic eyes, Patients with corneal pathology, previous refractive surgery or abnormalities in the anterior segment. For Stage 2 Study Normal 1. a history of glaucoma or any other ocular disease or systemic diseases such as diabetes and images were also excluded if they had unusable OCT scans due to poor signal strength (less than 6) or algorithm failure. Glaucoma 1. any history of previous retinal disease such as macular degeneration or optic nerve disease, including non-glaucomatous optic neuropathy. 2. Both normal and glaucoma images were also excluded if they had unusable OCT scans due to poor signal strength (less than 6) or algorithm failure, in which the boundaries for the RNFL layer were not delineated correctly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of this study is to compare the repeatability and reproducibility of the biometry and OCT measurements in Elisar NOA by calculating the Standard deviation(SD) and limits for the repeated measurement and compare with the indicative limits.Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr S Soundari
Dr Agarwals Eye Hospital
Outcome results
None listed